These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 3485053

  • 1. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
    Robak T, Hast R, Goldman JM.
    Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
    [Abstract] [Full Text] [Related]

  • 2. Erythroid progenitors in polycythemia vera demonstrate a different response pattern to IL-4 compared to the normal BFU-E from peripheral blood.
    de Wolf JT, Hendriks DW, Beentjes JA, Esselink MT, Smit JW, Halie MR, Vellenga E.
    Exp Hematol; 1991 Oct; 19(9):888-92. PubMed ID: 1893965
    [Abstract] [Full Text] [Related]

  • 3. Antigenic characteristics of erythropoietin dependent and independent erythroid progenitors (BFU-E and CFU-E) in polycythaemia vera and idiopathic myelofibrosis defined by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1988 Oct; 36(6):733-47. PubMed ID: 3254121
    [Abstract] [Full Text] [Related]

  • 4. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies.
    Robak T.
    Arch Immunol Ther Exp (Warsz); 1987 Oct; 35(4):519-29. PubMed ID: 3481543
    [Abstract] [Full Text] [Related]

  • 5. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 6. [Large volume, isovolemic erythrocytapheresis in treatment of polycythemia vera. Effect of massive iron depletion of proliferation behavior of erythroid precursor cells (BFU-E)].
    Liersch T, Vehmeyer K, Kaboth U.
    Med Klin (Munich); 1995 Jul 15; 90(7):390-7. PubMed ID: 7675003
    [Abstract] [Full Text] [Related]

  • 7. T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation.
    Ishii T, Zhao Y, Shi J, Sozer S, Hoffman R, Xu M.
    Leukemia; 2007 Dec 15; 21(12):2433-41. PubMed ID: 17713553
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human bone marrow-derived stem cell colony formation (CFU-E, BFU-E, and CFU-GM) following in vitro exposure to organophosphates.
    Gallicchio VS, Casale GP, Watts T.
    Exp Hematol; 1987 Dec 15; 15(11):1099-102. PubMed ID: 3678410
    [Abstract] [Full Text] [Related]

  • 15. Special Education.
    Kozutsumi H.
    Oncologist; 1996 Dec 15; 1(1 & 2):116-118. PubMed ID: 10387976
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lack of normal CFU-C/suppressor activity in population of alloantigen-stimulated T cells from patients with chronic myelogenous leukemia.
    Maekawa T, Sonoda Y, Yokota S, Abe T.
    Exp Hematol; 1986 May 15; 14(4):316-23. PubMed ID: 2938981
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
    Ferrero D, Tarella C, Pregno P, Pileri A, Gallo E.
    Cancer Res; 1986 Feb 15; 46(2):975-80. PubMed ID: 3455679
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.